We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > T-cell

News List

ViraCyte Announces Positive Phase 2 Trial Results americanpharmaceuticalreview
August 24, 2017
ViraCyte announced publication of positive data from a Phase 2 clinical trial evaluating its T-cell immunotherapy product, Viralym-M. The results were reported by ViraCyte lead investigators at Baylor College of Medicine in the Journal of Clinical Oncolog
Endocyte and Seattle Children’s Research Institute to Collaborate on Endocyte’s Small Molecule Drug americanpharmaceuticalreview
March 13, 2017
Endocyte, a developer of targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, announced their plan to collaborate with Seattle Children’s Research Institute and
Amgen, Immatics ink deal potentially worth over $1 billion to develop cancer immunotherapies firstwordpharma
January 10, 2017
Amgen and Immatics Biotechnologies on Monday announced an agreement potentially worth more than $1 billion to jointly develop next-generation T-cell engaging bispecific immunotherapies targeting multiple cancers

Previous page 1 2 Next page